XERS Xeris Biopharma Holdings Inc

10,150

$1.94

$0.02

(1.04%)

Today

Market Cap	$267.96M
Volume (M)	1,857.00
52-Wk High	$3.07
52-Wk Low	$0.9701

ST Data

Watchers

New Watcher Rank

Fundamentals

Xeris Biopharma Reports Third Quarter 2023 Financial ResultsBusiness Wire • 29 days ago

Share to Feed

Commit To Purchase Xeris Biopharma Holdings At $1.50, Earn 16.9% Annualized Using OptionsStock Options Channel • about 1 month ago

Investors eyeing a purchase of Xeris Biopharma Holdings Inc (XERS) stock, but cautious about paying the going market price of 1.97/share, might benefit from considering selling puts among the...

Xeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023Business Wire • about 2 months ago

Xeris Biopharma Announces Private Convertible Note Exchange TransactionsBusiness Wire • 2 months ago

Xeris to Participate in the 2023 Cantor Global Healthcare ConferenceBusiness Wire • 3 months ago

Xeris to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceBusiness Wire • 3 months ago

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside...

Xeris Biopharma Reports Second Quarter 2023 Financial ResultsBusiness Wire • 4 months ago

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced financial results for the second quarter and six months ended June 30...

Xeris Biopharma achieves record 2Q revenue and tightens full-year guidanceProactive Investors - UK • 4 months ago

Commit To Buy Xeris Biopharma Holdings At $1.50, Earn 14.8% Annualized Using OptionsStock Options Channel • 4 months ago

Investors eyeing a purchase of Xeris Biopharma Holdings Inc (XERS) stock, but tentative about paying the going market price of 2.58/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January ...